FASN and neoplasm: Mir-195 has been shown to target Bcl-2, inducing apoptosis, and target FASN, HMGCR, ACACA and CYP27B1 in hormone-receptor positive breast cancer cell lines, suppressing tumour growth, EMT, invasion and metastasis [39, 40].